Silva Pharmaceuticals Limited (DSE: SILVAPHL)
Bangladesh
· Delayed Price · Currency is BDT 13.90
-0.20 (-1.42%)
At close: Sep 12, 2024
Silva Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2016 |
| Net Income | -30.91 | 33.08 | 102.26 | 119.85 | 118.94 | 143.32 | Upgrade
|
| Depreciation & Amortization | 60.63 | 65.93 | 68.12 | 70.73 | 73.23 | 52.34 | Upgrade
|
| Other Amortization | 0.15 | 0.15 | 0.17 | 0.16 | 0.07 | - | Upgrade
|
| Other Operating Activities | -3.94 | -1.86 | -11.12 | 3.29 | 13.01 | -8.93 | Upgrade
|
| Change in Accounts Receivable | 5.22 | -1.71 | 14.6 | -8.79 | -4.17 | -9.47 | Upgrade
|
| Change in Inventory | -22 | -11.43 | -18.11 | -19.8 | -46.92 | -7.69 | Upgrade
|
| Change in Accounts Payable | 0.68 | 0.09 | 0.64 | -0.29 | 3.48 | -0.07 | Upgrade
|
| Change in Other Net Operating Assets | -26.49 | -14.15 | 4.3 | -5.76 | -7.02 | 20.47 | Upgrade
|
| Operating Cash Flow | -16.66 | 70.1 | 160.85 | 159.4 | 150.62 | 189.98 | Upgrade
|
| Operating Cash Flow Growth | - | -56.42% | 0.91% | 5.83% | -20.72% | 42.19% | Upgrade
|
| Capital Expenditures | 28.36 | -86.81 | -177.64 | -77.18 | -171.76 | -205.31 | Upgrade
|
| Investment in Securities | 86.86 | 72.32 | -13.38 | -8.63 | 48.76 | -166.8 | Upgrade
|
| Investing Cash Flow | 115.22 | -14.49 | -191.02 | -85.82 | -122.99 | -372.11 | Upgrade
|
| Short-Term Debt Issued | - | - | 61.87 | 2.46 | 26.68 | - | Upgrade
|
| Total Debt Issued | - | - | 61.87 | 2.46 | 26.68 | - | Upgrade
|
| Short-Term Debt Repaid | - | -35.17 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -3.2 | -6.18 | -6.49 | -5.59 | -99 | Upgrade
|
| Total Debt Repaid | -28.85 | -38.37 | -6.18 | -6.49 | -5.59 | -99 | Upgrade
|
| Net Debt Issued (Repaid) | -28.85 | -38.37 | 55.69 | -4.04 | 21.09 | -99 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 300 | Upgrade
|
| Common Dividends Paid | -14.75 | -25.03 | -47.75 | -47.3 | -52.95 | - | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.42 | -26.78 | Upgrade
|
| Financing Cash Flow | -43.6 | -63.4 | 7.94 | -51.34 | -32.28 | 174.22 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -1.33 | - | Upgrade
|
| Net Cash Flow | 54.95 | -7.78 | -22.24 | 22.25 | -5.98 | -7.91 | Upgrade
|
| Free Cash Flow | 11.7 | -16.7 | -16.8 | 82.22 | -21.14 | -15.33 | Upgrade
|
| Free Cash Flow Margin | 1.91% | -2.33% | -2.16% | 10.29% | -2.77% | -2.09% | Upgrade
|
| Free Cash Flow Per Share | 0.09 | -0.12 | -0.12 | 0.60 | -0.15 | -0.11 | Upgrade
|
| Cash Interest Paid | 3.32 | 2.73 | 4.06 | 1.74 | 0.42 | - | Upgrade
|
| Cash Income Tax Paid | 12.15 | 20.28 | 26.23 | 29.26 | 28.6 | 29.26 | Upgrade
|
| Levered Free Cash Flow | 21.65 | -28.2 | -48.45 | 53.24 | -58.5 | -65.27 | Upgrade
|
| Unlevered Free Cash Flow | 24.03 | -25.94 | -45.5 | 54.98 | -57.59 | -63.02 | Upgrade
|
| Change in Net Working Capital | 49.52 | 33.2 | 5.99 | 27.54 | 46.83 | -0.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.